A

Arcellx Inc
NASDAQ:ACLX

Watchlist Manager
Arcellx Inc
NASDAQ:ACLX
Watchlist
Price: 64.09 USD -2.89%
Market Cap: 3.5B USD
Have any thoughts about
Arcellx Inc?
Write Note

Wall Street
Price Targets

ACLX Price Targets Summary
Arcellx Inc

Wall Street analysts forecast ACLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACLX is 113.76 USD with a low forecast of 93.93 USD and a high forecast of 140.7 USD.

Lowest
Price Target
93.93 USD
47% Upside
Average
Price Target
113.76 USD
78% Upside
Highest
Price Target
140.7 USD
120% Upside
Arcellx Inc Competitors:
Price Targets
2162
KeyMed Biosciences Inc
37% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
37% Upside
9926
Akeso Inc
13% Upside
HUMA
Humacyte Inc
307% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
17% Downside
ZNTL
Zentalis Pharmaceuticals Inc
296% Upside
1530
3SBio Inc
1% Downside
ITOS
Iteos Therapeutics Inc
19% Upside

Revenue
Forecast

Revenue Estimate
Arcellx Inc

The compound annual growth rate of Arcellx Inc's revenue for the next 3 years is 33%.

N/A
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Arcellx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Arcellx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACLX's stock price target?
Price Target
113.76 USD

According to Wall Street analysts, the average 1-year price target for ACLX is 113.76 USD with a low forecast of 93.93 USD and a high forecast of 140.7 USD.

What is Arcellx Inc's Revenue forecast?
Projected CAGR
33%

The compound annual growth rate of Arcellx Inc's revenue for the next 3 years is 33%.

Back to Top